Effect of overexpressed adenylyl cyclase VI on β 1- and β 2-adrenoceptor responses in adult rat ventricular myocytes

British Journal of Pharmacology

Volumn 143, Issue 4, 2004, Pages 465-476

  Stark, Joalice C C ^a,b,c   Haydock, Stephen F ^c   Foo, Roger ^a   Brown, Morris J ^a   Harding, Sian E ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

1AR and 2AR; Adenylyl cyclase VI; Cardiomyocyte; Contractility; Coupling; Lusitropy

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ADENYLATE CYCLASE; ADENYLATE CYCLASE VI; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; COMPLEMENTARY DNA; CYCLIC AMP; FORSKOLIN; GREEN FLUORESCENT PROTEIN; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; UNCLASSIFIED DRUG; XAMOTEROL;

ADENOVIRUS; ADRENERGIC SYSTEM; ANIMAL CELL; ARTICLE; CELL DEATH; CONTROLLED STUDY; GENE OVEREXPRESSION; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE; NONHUMAN; PRIORITY JOURNAL; RAT; VIRUS INFECTION; VIRUS RECOMBINANT; WESTERN BLOTTING;

ADENYLATE CYCLASE; ANIMALS; CELL LINE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEART VENTRICLES; HUMANS; ISOPROTERENOL; MALE; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2;

EID: 7544242990     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705976     Document Type: Article

References (40)

1. BELL, D. & MCDERMOTT, B.J. (1994). Use of the cyclic AMP antagonist, Rp-cAMPS, to distinguish between cyclic AMP-dependent and cyclic AMP-independent contractile responses in rat ventricular cardiomyocytes. J. Mol. Cell. Cardiol., 26, 1439-1448.
2. CHAUDHRI, B., DEL MONTE, F., HAJJAR, R.J. & HARDING, S.E. (2003). Contractile effects of adenovirally-mediated increases in SERCA2a activity: a comparison between adult rat and rabbit ventricular myocytes. Mol. Cell. Biochem., 251, 103-109.
3. COMMUNAL. C., SINGH, K., PIMENTEL, D.R. & COLUCCI, W.S. (1998). Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway. Circulation, 98, 1329-1334.
4. COOPER, D.M. (2003). Molecular and cellular requirements for the regulation of adenylate cyclases by calcium. Biochem. Soc. Trans., 31, 912-915.
5. ESPINASSE, I., IOURGENKO, V., DEFER, N., SAMSON, F., HANOUNE, J. & MERCADIER, J.J. (1995). Type V, but not type VI, adenylyl cyclase mRNA accumulates in the rat heart during ontogenic development. Correlation with increased global adenylyl cyclase activity. J. Mol. Cell. Cardiol., 27, 1789-1795.
6. ESPINASSE, I., IOURGENKO, V., RICHER, C., HEIMBURGER, M., DEFER, N., BOURIN, M.C., SAMSON, F., PUSSARD, E., GIUDICELLI, J.F., MICHEL, J.B., HANOUNE, J. & MERCADIER, J.J. (1999). Decreased type VI adenylyl cyclase mRNA concentration and Mg(2+)-dependent adenylyl cyclase activities and unchanged type V adenylyl cyclase mRNA concentration and Mn(2+)-dependent adenylyl cyclase activities in the left ventricle of rats with myocardial infarction and longstanding heart failure. Cardiovasc. Res., 42, 87-98.
7. GAO, M.H., BAYAT, H., ROTH, D.M., YAO, Z.J., DRUMM, J., BURHAN, J. & HAMMOND, H.K. (2002). Controlled expression of cardiac-directed adenylyl cyclase type VI provides increased contractile function. Cardiovasc. Res., 56, 197-204.
8. GAO, M., PING, P., POST, S., INSEL, P.A., TANG, R. & HAMMOND, H.K. (1998). Increased expression of adenylyl cyclase type VI proportionately increases β-adrenergic receptor-stimulated production of cAMP in neonatal rat cardiac myocytes. Proc. Natl. Acad. Sci. U.S.A., 95, 1038-1043.
9. 2- adrenoceptor. Br. J. Pharmacol., 131, 594-600.
10. 2AR in myocytes from failing human heart. Circulation, 105, 2497-2503.
11. ISHIKAWA, Y., GRANT, B.S., OKUMURA, S., SCHWENCKE, C. & YAMAMOTO, M. (2000). Immunodetection of adenylyl cyclase protein in tissues. Mol. Cell. Endocrinol., 162, 107-112.
12. KATANO, Y. & ENDOH, M. (1993). Cyclic AMP metabolism in intact rat ventricular cardiac myocytes: interaction of carbachol with isoproterenol and 3-isobutyl-1-methylxanthine. Mol. Cell. Biochem., 119, 195-201.
13. KATSUSHIKA, S., CHEN, L., KAWABE, J., NILAKANTAN, R., HALNON, N.J., HOMCY, C.J. & ISHIKAWA, Y. (1992). Cloning and characterization of a sixth adenylyl cyclase isoform: types V and VI constitute a subgroup within the mammalian adenylyl cyclase family. Proc. Natl. Acad. Sci. U.S.A., 89, 8774-8778.
14. 2-adrenoceptors in the stimulation of adenylate cyclase and contractile force. Eur. Heart J., 10, 29-37.
15. 2-Adrenergic receptor actions in neonatal and adult rat ventricular myocytes. Circ. Res., 76, 40-52.
16. LOHSE, M.J., ENGELHARDT, S. & ESCHENHAGEN, T. (2003). What is the role of β-adrenergic signaling in heart failure? Circ. Res., 93, 896-906.
17. MCMANUS, M.T. & SHARP, P.A. (2002). Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet., 3, 737-747.
18. NOVOTNY, J., HRBASOVA, M., KOLAR, F. & SVOBODA, P. (2003). Cardiomegaly induced by pressure overload in newborn rats is accompanied by altered expression of the long isoform of G(s)alpha protein and deranged signaling of adenylyl cyclase. Mol. Cell. Biochem., 245, 157-166.
19. OSTROM, R.S., GREGORIAN, C., DRENAN, R.M., XIANG, Y., REGAN, J.W. & INSEL, P.A. (2001). Receptor number and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase. J. Biol. Chem., 276, 42063-42069.
20. PATERSON, J.M., SMITH, S.M., SIMPSON, J., GRACE, O.C., SOSUNOV, A.A., BELL, J.E. & ANTONI, F.A. (2000). Characterisation of human adenylyl cyclase IX reveals inhibition by Ca(2+)/ calcineurin and differential mRNA polyadenylation. J. Neurochem., 75, 1358-1367.
21. PING, P., ANZAI, T., GAO, M. & HAMMOND, H.K. (1997). Adenylyl cyclase and G protein receptor kinase expression during development of heart failure. Am. J. Physiol., 273, H707-H717.
22. RAIMUNDO, S., GIRAY, J., VOLFF, J.N., SCHWAB, M., ALTENBUCHNER, J., RATGE, D. & WISSER, H. (1999). Cloning and sequence of partial cDNAs encoding the human type V and VI adenylyl cyclases and subsequent RNA-quantification in various tissues. Clin. Chim. Acta, 285, 155-161.
23. ROTH, D.M., BAYAT, H., DRUMM, J.D., GAO, M.H., SWANEY, J.S., ANDER, A. & HAMMOND, H.K. (2002). Adenylyl cyclase increases survival in cardiomyopathy. Circulation, 105, 1989-1994.
24. SAITO, S., HIROI, Y., ZOU, Y., AIKAWA, R., TOKO, H., SHIBASAKI, F., YAZAKI, Y., NAGAI, R. & KOMURO, I. (2001). β-Adrenergic pathway induces apoptosis through calcineurin activation in cardiac myocytes. J. Biol. Chem., 275, 34528-34533.
25. SANDIRASEGARANE, L. & DIAMOND, J. (2004). Pertussis toxin-sensitive G protein but not NO/cGMP pathway mediates the negative inotropic effect of carbachol in adult rat cardiomyocytes. Pharmacol., 70, 46-56.
26. SATO, M., GONG, H., TERRACCIANO, C.M., RANU, H. & HARDING, S.E. (2004). Loss of β-adrenoceptor response in myocytes over-expressing the Na+/Ca(2+)-exchanger. J. Mol. Cell. Cardiol., 36, 43-48.
27. SCHWENCKE, C., OKUMURA, S., YAMAMOTO, M., GENG, Y.J. & ISHIKAWA, Y. (1999a). Colocalization of β-adrenergic receptors and caveolin within the plasma membrane. J. Cell. Biochem., 75, 64-72.
28. SCHWENCKE, C, YAMAMOTO, M., OKUMURA, S., TOYA, Y., KIM, S.J. & ISHIKAWA, Y. (1999b). Compartmentation of cyclic adenosine 3′, 5′-monophosphate signaling in caveolae. Mol. Endocrinol., 13, 1061-1070.
29. SEAMON, K.B., PADGETT, W. & DALY, J.W. (1981). Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc. Natl. Acad. Sci. U.S.A., 78, 3363-3367.
30. SOSUNOV, S.A., KEMAIKIN, S.P., KURNIKOVA, I.A., ANTONI, F.A. & SOSUNOV, A.A. (2001). Expression of adenylyl cyclase type IX and calcineurin in synapses of the central nervous system. Bull. Exp. Biol. Med., 131, 172-175.
31. TAUSSIG, R. & GILMAN, A.G. (1995). Mammalian membrane-bound adenylyl cyclases. J. Biol. Chem., 270, 1-4.
32. 1- adrenoceptor blockade on the gene expression of adenylate cyclase subtypes and β-adrenoceptor kinase in human atrium. Clin. Sci., 101, 211-217.
33. WOOLF, N., DAVIES, M.J., SHAW, M.J. & TRICKEY, R.J. (1976). Experiences with isoprenaline induced myocardial necrosis in the rat. J. Pathol., 120, 65-73.
34. 2+ dynamics, contractility or phospholamban phosphorylation. J. Biol. Chem., 269, 19151-19156.
35. 2- adrenoceptors in neonatal cardiac myocytes. J. Biol. Chem., 277, 34280-34286.
36. 1,-AR-mediated positive inotropic effect in myocytes from failing rat hearts. Circulation, 108, 1633-1639.
37. ZACCOLO, M. & POZZAN, T. (2002). Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Sci., 295, 1711-1715.
38. 2-adrenoceptor. J. Biol. Chem., 275, 21773-21779.
39. 2 double knockout mice. Mol. Pharmacol., 58, 887-894.
40. 1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. J. Clin. Invest., 111, 617-625.